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httpcense.Abstract Background: Chronic obstructive pulmonary disease (COPD) is no longer considered to
affect only the lungs and airways but also the rest of the body. The systemic manifestations of
COPD include a number of endocrine disorders, such as those involving the pituitary, the thyroid,
the gonads, the adrenals and the pancreas. The severity of airway obstruction in chronic obstructive
pulmonary diseases (COPD) is associated with the impairment of thyroid gland function.
Aim of work: This study was carried out to evaluate thyroid abnormalities in patients with
COPD and relationship between pulmonary function tests, arterial blood gases and thyroid func-
tions.
Patients and methods: Serum free triiodothyronine (ft3), free thyroxin (ft4), and thyroid stimu-
lating hormone(TSH) were measured in 50 patients with COPD and 50 healthy volunteers (control
group) and its relation to some ventilatory function tests (FEV1/FVC, FEV1, FVC%, and FEF25-
75) and ABG parameters (PH, Paco2, Pao2, Hco3 and O2 saturation) were studied.
Results: There was no signiﬁcant difference in mean levels of TSH, FT3 and FT4 between
COPD and control group. The mean values of free T3, free T4, and TSH were within normal limits
in both groups however, free T3 values in the case group were toward upper normal limits and the
mean values of free T3 were increased in the case group compared to their values in the control
group. The mean values of free T3 of the cases were signiﬁcantly increasing with increased severity4, thyroxin; TSH, thyroid-
hyronine; fT4, free thyroxin;
thyroxin
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388 H.A. Abo El-Yazed et al.of COPD. Signiﬁcant negative correlations were present between free T3 levels and pulmonary
function tests of the cases. Signiﬁcant negative correlations were present between free T3 levels
and both PaO2 and SO2 of the cases and also show a signiﬁcant positive correlation between free
T3 levels and PaCO2 of the cases.
Conclusion: Thyroid function tests among COPD patients showed a signiﬁcant increase of the
mean free T3 values and a non signiﬁcant decrease of the mean free T4 and TSH values compared
to the control group. With increasing severity of COPD, the mean free T3 values showed a signif-
icant increase. Signiﬁcant negative correlations were noticed between free T3 levels and both PaO2
and SO2 of the cases. A signiﬁcant positive correlation was observed between free T3 levels and
PaCO2 of the cases. Signiﬁcant negative correlations were observed between free T3 levels and pul-
monary function tests of the cases.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.Introduction
Chronic obstructive pulmonary disease (COPD) is a prevent-
able and treatable disease with signiﬁcant extra-pulmonary ef-
fects that may contribute to the severity in individual patients.
Its pulmonary component is characterized by airﬂow limita-
tion that is not fully reversible. The airﬂow limitation is usually
progressive and associated with an abnormal inﬂammatory re-
sponse of the lung due to exposure to noxious particles or
gases. COPD affects the lungs and produces systemic conse-
quence [1]. Abnormalities in thyroid hormone regulation are
encountered frequently in nonthyroidal diseases; these include
normal or decreased total and free thyroxine (TT4 and FT4
respectively), decreased total (TT3) and free (FT3) triiodothy-
ronine along with usually normal thyroid-stimulating hormone
(TSH) levels [1]. These changes have been observed primarily
in critical illness, such as starvation, sepsis, surgery, or myocar-
dial infarction, but also in diverse chronic, systemic conditions,
i.e., in chronic heart failure, chronic liver or hematological dis-
eases, cancer, diabetes, and in connective tissue disorders [2].
Chronic obstructive pulmonary disease (COPD) is a major
cause of chronic morbidity and mortality throughout the
world, leading to years of suffering and premature death from
it or its complications [3]. The severity of airway obstruction in
COPD is associated with the impairment of thyroid gland
function [4]. There is an apparent clinical resemblance between
a hyperthyroid state and advanced COPD. Early detection of
thyroid disturbances may therefore be clinically important in
COPD [5]. In the present study, we evaluated thyroid abnor-
malities in patients with COPD and relationship between pul-
monary function tests, arterial blood gases and thyroid
functions.
Aim of the Work: This study was carried out to evaluate
thyroid abnormalities in patients with COPD and relationship
between pulmonary function tests, arterial blood gases and
thyroid functions.Subjects and methods
This study was conducted on 50 patients with COPD and 50
healthy volunteers (control group). They were selected from
the Department of Chest diseases, Al-Hussein University Hos-
pital, Al-Azhar University over a period of one year from June
2011 to June 2012.Study design
Case control study
 Subjects
Fifty patients diagnosed as COPD according to
(GOLD); 47 males and 3 females with an age range of
48 to 75 years (mean 61.8 ± 7.5 years).
A control group of 50 healthy smokers’ subjects with age
and sex match was included; 45 males and 5 females with
age ranging from 47 to 72 years (mean
59.4 ± 6.8 years).
 Inclusion criteriaPatients diagnosed as COPD according to Global Initia-
tive for chronic obstructive lung disease criteria
(GOLD).
 Exclusion criteria
Patients with known chronic chest diseases other than
COPD.
Patients with known hypothyroidism, hyperthyroidism,
or previous thyroid surgery.
Patients with other diseases or illnesses that might affect
thyroid functions e.g., endocrinal, metabolic, autoim-
mune disorders, etc.
Patients on any regular medication, other than the
COPD drugs, that might affect thyroid functions, such
as iodine-containing drugs, amiodarone and immuno-
suppressive drugs.
All patients were subjected to the followings:
–– Full history taking and clinical examination.
–– Plain chest X-ray postero-anterior view.
–– Complete blood picture, liver and kidney functions.
–– Pulmonary function (Spirometry): In pulmonary function
unit in the Chest Department, Al-Hussein University Hos-
pital. Reversibility test was done to differentiate between
COPD and bronchial asthma, pre and 15 min post bron-
chodilator (400 micrograms salbutamol by meter dose inha-
ler) FEV1 done. All COPD patients had post
bronchodilator response less than 12% of absolute FEV1.
 The severity of COPD was rated according to GOLD, 2010
and depends on post bronchodilator FEV1 [1].
–– Arterial blood gas analysis (ABG): it was done in all cases.
389–– Serum levels of free triiodothyronine (FT3), free thyroxin
(FT4) and thyroid-stimulating hormone (TSH) were ana-
lyzed in the Endocrinal Unit Laboratory of the Clinical
Pathology Department at Al-Hussein University Hospital.
All patients were ex-smokers and they were clinically in
exacerbation. All patients received medication related to
COPD (inhaler/oral bronchodilators and intravenous/oral
steroid, and antibiotics). The patients were not receiving
iodine-containing drugs.
–– The control group was recruited from the outpatient clinic
of non-chronic chest diseases and from other departments
as those assessed before minor surgeries. Control groups
comprised of patients without COPD. They submitted to
history taking, examination, and measurement of T3, T4,
TSH, and spirometry.
Results
The mean ± SD of age in the COPD group was
61.7 ± 7.7 years while that of the control group was
59.4 ± 6.8 years and there was no signiﬁcant difference be-
tween two groups (P-value = 0.123). 47 COPD patients were
men (94%) and 3 patients were women (6%), while 45 persons
of control group were men (90%) and 5 were women (10%).
94% of COPD patients were smokers and 80% of control sub-
jects were smokers.
Table 1: The mean values of smoking index of the cases
were signiﬁcantly higher than those of controls.
–– The mean values of oxygen saturation (SO2) of the cases
were signiﬁcantly lower than those of controls.
–– The mean values of pulmonary function tests (FEV1, FVC
and FEV1/FVC) of the cases were lower than those of con-
trols with a statistical signiﬁcant difference.
–– The mean values of thyroid function tests (free T3, free T4
and TSH) of the cases were higher (to upper normal range)
than those of controls however; statistical signiﬁcance was
observed only regarding free T3 levels.
Table 2: With increased severity of COPD:
–– The mean values of arterial blood gases (PaO2 and SO2) of
the cases were signiﬁcantly decreasing while the mean val-
ues of PaCO2 were signiﬁcantly increasing.Table 1 Comparison between cases and controls regarding smoking
Variables Cases No. = 50 Co
Smoking index 661.0 ± 245.2 79
SO2 (%) 90.4 ± 3.9 96
FEV1 (%) 58.3 ± 19.4 86
FVC (%) 68.7 ± 12.5 87
FEV1/FVC (%) 52.1 ± 10.2 96
T3 (pg/mL) 3.0 ± 0.6 1
T4 (pg/dL) 1.2 ± 0.4 1
TSH (lIU/mL) 1.9 ± 1.2 1
Values presented as mean ± SD and analyzed by Independent samples t
* Signiﬁcant.
** Highly signiﬁcant.–– The mean values of pulmonary function tests (FEV1, FVC
and FEV1/FVC) of were signiﬁcantly decreasing. The mean
values of free T3 of the cases were signiﬁcantly increasing.
Table 3: Signiﬁcant negative correlations present between
free T3 levels and PaO2, SO2 and pulmonary function tests
of the cases and also a signiﬁcant positive correlation present
between free T3 levels and PaCO2 of the cases.
Statistical analysis of data
Statistical analysis was carried out using the SPSS computer
package version 17.0 (SPSS Inc., Chicago, IL, USA). The
mean ± SD was used for quantitative variables while number
and% were used for qualitative variables. In order to assess the
differences in means of quantitative variables between patients
and controls, Independent samples t-test was applied. In order
to assess the differences in means of quantitative variables
within the patients group, One-Way ANOVA test was used.
Correlation analysis (using Pearson’s correlation coefﬁcient)
was used to assess the strength of association between various
quantitative variables within the patients’ group. The statisti-
cal methods were veriﬁed, assuming a signiﬁcance level of
p< 0.05 and a highly signiﬁcant level of p< 0.001.
Discussion
Chronic obstructive pulmonary disease (COPD) is no longer
considered to affect only the lungs and airways but also the
rest of the body [1]. The systemic manifestations of COPD in-
clude a number of endocrine disorders, such as those involving
the pituitary, the thyroid, the gonads, the adrenals and the
pancreas. The severity of airway obstruction in chronic
obstructive pulmonary diseases (COPD) is associated with
the impairment of thyroid gland function [2]. There is an
apparent clinical resemblance between a hyperthyroid state
and advanced chronic obstructive pulmonary disease (COPD).
In both conditions tachycardia, weight reduction and loss of
muscle mass may be found [5]. In COPD complicated by hyp-
oxemia these traits may be aggravated, since chronic or inter-
mittent hypoxemia may trigger a hypermetabolic state causing
depletion of fat free mass [2].
The mean± SD of age in the COPD group was 61.7 ± 7.7
years while that of the control group was 59.4 ± 6.8 years and
there was no signiﬁcant difference between two groups
(P-value = 0.123). 47 COPD patients were men (94%) and 3index, arterial blood gases, pulmonary and thyroid function tests.
ntrols No. = 50 T P-value
.6 ± 15.5 14.3 <0.001**
.8 ± 1.2 11.2 <0.001**
.4 ± 4.8 9.9 <0.001**
.6 ± 4.4 10.1 <0.001**
.8 ± 21.6 3.1 0.003*
.4 ± 0.6 6.4 0.002*
.1 ± 0.3 0.5 0.640
.8 ± 1.1 0.2 0.842
-test.
Table 2 Relation between severity of COPD and arterial blood gases, pulmonary and thyroid function tests of the cases.
Variables Mild No. = 11 Moderate No. = 13 Severe No. = 13 Very severe No. = 13 F P-value
PaO2 76.4 ± 2.9 67.7 ± 4.1 56.8 ± 2.3 50.5 ± 2.6 16.6 <0.001**
PaCO2 38.7 ± 1.3 42.3 ± 1.6 50.0 ± 2.7 62.5 ± 3.3 24.1 <0.001**
SO2 95.6 ± 1.4 92.1 ± 1.1 88.9 ± 0.8 85.6 ± 1.5 15.5 <0.001**
FEV1 83.3 ± 2.6 70.0 ± 6.2 49.8 ± 5.8 33.9 ± 4.4 29.7 <0.001**
FVC 82.8 ± 2.4 76.6 ± 2.3 64.8 ± 3.6 51.8 ± 4.3 20.0 <0.001**
FEV1/FVC 65.9 ± 1.9 57.1 ± 3.3 48.5 ± 3.0 39.2 ± 2.6 16.6 <0.001**
T3 2.4 ± 0.2 2.9 ± 0.2 3.4 ± 0.2 4.0 ± 0.1 78.2 <0.001**
T4 1.0 ± 0.4 1.3 ± 0.3 1.1 ± 0.4 1.1 ± 0.4 1.7 0.190
TSH 2.3 ± 1.5 1.8 ± 0.8 1.7 ± 1.0 1.9 ± 1.4 0.6 0.613
Values presented as mean ± SD and analyzed by One-Way ANOVA test.
** Highly signiﬁcant.
Table 3 Correlation between arterial blood gases and pulmonary function tests and T3 levels of the cases.
PaO2 PaCO2 SO2 FEV1 FVC FEV1/FVC
T3 r 0.9 0.8 0.9 0.8 0.8 0.3
P-value <0.001** <0.001** <0.001** <0.001** <0.001** 0.005*
r: Pearson correlation test.
* Signiﬁcant.
** Highly signiﬁcant.
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were men (90%) and 5 were women (10%). 94% of COPD pa-
tients were smokers and 80% of control subjects were smokers.
This study is coinciding with Okutan et., al. (2004) study as they
reported that the mean ± SD of age of COPD patients was
64.1 ± 7.3 years and that of the control group was
61.7 ± 5.2 years and they also reported male predominance in
the COPD group (22/32) and control group(9/15) [6]. In addi-
tion, most of their COPD patients were smokers (62.5%) and
100% of the control group were smokers. Magd et al. (2011)
study as they reported that the mean ± SD of age of COPD pa-
tients was 58.23 ± 7.6 years and that of the control group was
56.6 ± 5.7 years and they also reported male predominance in
the COPD group while female predominance in the control
group. In addition, most of their COPD patients were smokers
(93.3%) and 100% of the control group were smokers [7].
This study declared a signiﬁcant reduction in mean values
of pulmonary function tests; FEV1, FVC, and FEV1/FVC in
the patients’ group compared to their values in the control
group (p< 0.001, p< 0.001 and p= 0.003 respectively).
These ﬁndings coincide with those reported by Okutan et al.
(2004) who found that, the values of the pulmonary function
tests (VC, FVC, FEV1 and PEF) were lower in the study than
in the control group [6].
This study found that all COPDpatients and control subjects
had normal ft3, ft4, and TSH levels. However, free T3 values in
the patients’ group were toward upper normal limits and the
mean values of free T3 were increased in the patients’ group
compared to their values in the control group with a statistical
signiﬁcant difference (p= 0.002). This is in agreement with
Dimopoulou et al. (2001) who found that all patients had
normal values for resting thyroid hormones. However, in severe
COPD, a certain degree of thyroid dysfunction was evident [8].
This is in agreement with Magd et al. (2011) study as theyreported that all COPD patients and control subjects had
normal ft3, ft4, and TSH levels [7]. Uzun et al. (2007) reported
that the mean levels of thyroid functions were normal in COPD
patients (all patients had severe COPD) and control groups, but
there was lower TSH than normal limits in 20 patients with
COPD and in 2 patients without COPD [2]. Creutzberg and
Casabur (2003) found, no evidence has been presented so far
that thyroid function is substantially altered in COPD, except
perhaps in a subgroup of patients with severe hypoxemia [9].
Okutan et al. (2004) revealed that, free T3 levels of the cases were
signiﬁcantly higher than controls (p< 0.001) and this agree
with the results of this study [8]. This is in disagreement with
Jack (2012) who found that the serum TT3, FT3, TT4, and h-
TSH expression level of the COPDgroup and nonCOPD group
was statistically signiﬁcant (P< 0.05), FT4 was not statistically
signiﬁcant (P> 0.05) [10]. This is also disagreed with Hefney
et al. (2009) who found that 4 patients (20%) had normal
thyroid function and 3 patients had hypothyroidism, while only
one patient had subclinical hyperthyroidism. This difference
might be due to that Hefney et al. studied prolonged mechani-
cally ventilated COPD patients (more than 2 weeks) and this
study studied stable COPD cases [11].
This study showed that: with increased severity of COPD:
the mean values of arterial blood gases (PaO2 and SO2) of
the cases were signiﬁcantly decreasing while the mean values
of PaCO2 were signiﬁcantly increasing and the mean values
of pulmonary function tests (FEV1, FVC and FEV1/FVC)
were signiﬁcantly decreasing and the mean values of free T3
of the cases were signiﬁcantly increasing (toward upper normal
value). Okutan et al. (2004) showed the values of the pulmon-
ary function tests (vital capacity, forced vital capacity, forced
expiratory volume in 1 s and peak expiratory ﬂow) and
PaO2 were lower in the study than the control group (p!
0.001), but the values of PaCO2 and concentration of free
391triiodothyronine (fT3) were higher in the study than the con-
trol group (p ! 0.01) although thyroid hormone concentrations
were within normal limits in all cases [6]. Dimopoulou et al.
(2001) found that there is a strong positive correlation between
TT3, TT4, and TT3% and TT4 with FEV1 only if FEV1 was
less than 50% [8]. This is disagreed with Banks and Cooper
(1990) who found no relationship between hormonal levels
and lung function in patients with chronic obstructive lung dis-
ease, and they suggested that most of endocrine dysfunction
ascribed to COPD were probably due to factors other than hy-
poxia or hypercapnia [12]. This is also disagreed with Magd
et al. (2011) who found no signiﬁcant correlation between hor-
monal levels and lung function in COPD patients [7].
This study also showed signiﬁcant negative correlations
present between free T3 levels and PaO2, SO2 and pulmonary
function tests of the cases and also a signiﬁcant positive corre-
lation present between free T3 levels and PaCO2 of the cases.
This is in agreement with Uzun et al. (2007) who found a neg-
ative correlation between FT3 and PaO2 and PFT (2). Differ-
ent results reported by Magd et al. (2011) found a signiﬁcant
positive correlation between FT4 and HCO3 and a signiﬁcant
inverse correlation between FT4 and PaO2 and a highly signif-
icant positive correlation between FT4 and PaCO2 [7]. These
ﬁndings coincide with the study done by Laghi et al. (2009)
who found that a positive association was found between
PaCO2 and free T3, and no association between TSH and free
T4 on the one hand, and pulmonary function tests and arterial
blood gases on the other, the difference in the results may be
due to the investigation of hormonal changes during exacerba-
tion of COPD [13].
Conclusion
Thyroid function tests among COPD patients showed a signif-
icant increase of the mean free T3 values and a non signiﬁcant
decrease of the mean free T4 and TSH values compared to the
control group. With increasing severity of COPD, the mean
free T3 values showed a signiﬁcant increase. Signiﬁcant nega-
tive correlations were noticed between free T3 levels and both
PaO2 and SO2 of the cases and a signiﬁcant positive correla-
tion was observed between free T3 levels and PaCO2 of the
cases. Signiﬁcant negative correlations were observed between
free T3 levels and pulmonary function tests of the case.
Recommendations
–– Measurement of thyroid gland functions is important to
predict the systemic effects of COPD.–– A sound understanding of the various disorders of endo-
crine function associated with COPD is important for every
physician who practices pulmonary medicine.
–– Another study which measures total T3 and total T4 to
detect peripheral conversion of T4 into T3 is recommended.
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